Biotechnology Buyers & Acquisitions in Michigan

Tracked deals

5

5 tracked deals across 2020-2025.

Buyer mix

Strategic-led

5 strategic · 1 pe

Top trend

Volume peaked in 2020

3 tracked deals announced in 2020.

Buyer Snapshot

Top Buyers

Illustrative buyers pulled from tracked transactions on this page. This table is capped and intentionally non-exhaustive.

Build a buyer list for your Biotechnology deal →
Buyer # Deals Focus Type
Ampersand Capital Partners 1 Middle-market private equity firm focused on growth-orien... PE
Bio-Rad Laboratories, Inc. 1 Global developer, manufacturer, and marketer of life scie... Strategic
Integrated DNA Technologies (IDT) 1 Comprehensive genomics solutions provider that develops a... Strategic
NanoImaging Services 1 Provider of cryo-electron microscopy (cryo-EM), TEM and s... Strategic (PE-backed)
Shionogi & Co., Ltd. 1 Research-driven pharmaceutical company focused on infecti... Strategic
StemBioSys, Inc. 1 Privately held biomedical company that develops and manuf... Strategic

Acquisition Volume in Biotechnology in Michigan by Year

Last 3 years

Acquisition volume by year Annual acquisition counts for the last 3 years for Biotechnology Buyers & Acquisitions in Michigan. 3 2020 1 2021 1 2025

Supporting Data

Recent Transactions

  • NanoImaging Services Acquires Proteos
    January 5, 2025
    Buyer
    NanoImaging Services, Ampersand Capital Partners
    Target
    Proteos, Inc.
    Industry
    Biotechnology
    Location
    Michigan, United States
    Type
    Addon

    NanoImaging Services (NIS), a cryo-electron microscopy services provider backed by Ampersand Capital Partners, has acquired Proteos, Inc., a Kalamazoo-based CRO specializing in recombinant protein and antibody production. The add-on acquisition integrates Proteos’ protein production capabilities with NIS’s cryo-EM services to create an end-to-end offering for structure-based drug discovery and protein production workflows.

  • Integrated DNA Technologies Acquires Swift Biosciences
    March 11, 2021
    Buyer
    Integrated DNA Technologies (IDT)
    Target
    Swift Biosciences
    Industry
    Biotechnology
    Location
    Michigan, United States
    Type
    Buyout

    Integrated DNA Technologies (IDT) has acquired Swift Biosciences, a developer of Next-Generation Sequencing (NGS) library preparation and enrichment kits. The acquisition brings Swift's library prep and enrichment portfolio and Ann Arbor-based team into IDT to expand IDT's NGS product offerings and accelerate growth in academic, translational, and clinical research markets. Financial terms were not disclosed.

  • Shionogi Acquires Tetra Therapeutics
    May 26, 2020
    Buyer
    Shionogi & Co., Ltd.
    Target
    Tetra Therapeutics
    Industry
    Biotechnology
    Location
    Michigan, United States
    Type
    Buyout

    Shionogi & Co., Ltd. agreed to acquire clinical-stage biopharmaceutical company Tetra Therapeutics, giving Shionogi global rights to Tetra's portfolio including BPN14770. The deal, announced May 26, 2020, is valued at up to $500 million in milestone and contingent payments.

  • Bio-Rad Acquires Celsee, Inc.
    April 9, 2020
    Buyer
    Bio-Rad Laboratories, Inc.
    Target
    Celsee, Inc.
    Industry
    Biotechnology
    Location
    Michigan, United States
    Type
    Buyout

    Bio-Rad Laboratories has acquired Celsee, Inc., a developer of instruments and consumables for single-cell isolation, detection and analysis. The acquisition expands Bio‑Rad’s capabilities in single-cell analysis and precision medicine; terms were not disclosed.

  • StemBioSys Acquires Majority Stake in Cartox
    January 8, 2020
    Buyer
    StemBioSys, Inc.
    Target
    CARTOX, Inc.
    Industry
    Biotechnology
    Location
    Michigan, United States
    Type
    Buyout

    San Antonio-based StemBioSys acquired a majority stake in Ann Arbor startup Cartox, obtaining control with plans to purchase the remaining equity subject to milestones. The deal brings Cartox's cardiotoxicity imaging and assay capabilities together with StemBioSys's CELLvo extracellular matrix technology to accelerate commercial development of pre-clinical cardiac safety and efficacy screening solutions.

Build a buyer list for your Biotechnology deal

Find buyers actively acquiring biotechnology companies.

Apply as a Buyer

Related Acquisition Pages

Biotechnology Buyers & Acquisitions Biotechnology Buyers & Acquisitions in Canada Private Equity-Backed Biotechnology Buyers Biotechnology Acquisitions in 2025 Biotechnology Acquisitions in 2021 Biotechnology Acquisitions in 2020 Acquisitions in Michigan Private Equity-Backed Acquisitions in Michigan Acquisitions in Michigan in 2025 Acquisitions in Michigan in 2021 Acquisitions in Michigan in 2020